跳至主要内容
临床试验/IRCT201601289014N90
IRCT201601289014N90已完成2 期

Effect of citicoline versus placebo on clinical signs in patients with acute ischemic and hemorrhagic stroke: a triple blind control trial

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 85 years(—)
性别
All

入选标准

  • (a) age of 18 to 85 years; (b) acute stroke; (c) NIHSS score between 6 to 22.
  • Exclusion criteria: (a) previous history of stroke; (b) renal or liver failure; (c) cancer; (d) active infectious disease during last month; (e) trauma or surgery during last month; (f) history of collagen vascular disease; (g) immunosuppressive medications or corticosteroid; (h) signs of brain hernia; (i) convulsion at the time of stroke; (j) neurologic disease or dementia; (k) pregnancy or breastfeeding; (l) receiving vasodilator medications.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences

相似试验